In many European countries, patients with a variety of chronical inflammatory diseases are treated with low-dose radiotherapy (LD-RT). In contrast to high-dose irradiation given to tumor patients, little is known about radiobiological mechanisms underlying this...
Eat, Sleep, Radiate, Repeat. Xstrahl is delighted to invite you to attend its booth at the 64th Annual Meeting of the Radiation Research Society held at the Historic Hilton Chicago Hotel on September 23-26, 2018, in conjunction with the Conference on Radiation &...
Cancer treatment has come a long way in a short time, however as new drugs and treatments are developed, the therapeutic index of treatments needs to be assessed. In their study “Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in...
Radiotherapy enhances innate and adaptive antitumor immunity; however, the effects of radiation on suppressive immune cells, such as regulatory T cells (Treg), in the tumor microenvironment (TME) are not fully elucidated. Although previous reports suggest an increased...
Sydney Vital, a translational cancer research centre funded by the Cancer Institute New South Wales (CINSW) and the University of Sydney, is the first centre in Australia to acquire an Xstrahl Small Animal Radiation Research Platform (SARRP). Sydney Vital’s aim is to...
High-precision radiotherapy requires precise positioning, particularly with high single doses. Fiducial markers in combination with onboard imaging are excellent tools to support this. In the study “BioXmark for high-precision radiotherapy in an orthotopic pancreatic...
Surgery is the gold standard for treating basal cell carcinomas (BCCs), however in cases of positive tumor margins or recurrent disease, postoperative adjuvant or salvaging therapy is prefered to achieve good local control. In their paper “Orthovoltage X-rays for...
The development of image-guided small animal irradiators represents a significant improvement over standard irradiators by enabling preclinical studies to mimic radiotherapy in humans. The ability to deliver tightly collimated targeted beams, in conjunction with...
Radiation-induced erectile-dysfunction (RiED) is one of the most common side effects of radiation therapy and significantly reduces the quality of life of cancer patients. Approximately 50% of prostate cancer patients experience RiED within 3 to 5 years after...
Contact Us